Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Determinants for Therapy Response on Renal Cell Carcinoma

NCT02208128 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT02208128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02208128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Determinants for Therapy Response on Renal Cell Carcinoma
Lead sponsor
Heidelberg University
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2014
Completion date
February 28, 2018
Enrollment
4 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma